|
Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response in castration-resistant patients. |
|
Camilla Thellenberg Karlsson |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - ThromboDX (I) |
|
|
Consulting or Advisory Role - Astellas Oncology; Bayer; Sanofi |
Speakers' Bureau - Astellas Oncology; EXINI Diagnostics |
|
|
Patents, Royalties, Other Intellectual Property - ThromboDx |
|
|
No Relationships to Disclose |